×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Incathlab member and receive full access to its content!

You must be an Incathlab member to access videos without any restrictions. Register for free in one minute and access all services provided by Incathlab.You will also be able to log into Incathlab from your Facebook or twitter account by clicking on login on the top-right corner of Incathlab website.

Registration Login


Worldwide schedules comment Share

Please give us your feedback after the live

Fill the survey →

Program

12:30 Introduction & Presentation
 
12:35
DCB in “small” coronary vessels: from evidence to daily practice
Prof Raban Jeger
Panel discussion
 
13:00
 
Cases in box: DCB in difficult anatomies with follow up
Dr Daniel Weilenmann
Panel discussion
 
13:30
DCB: does the drug matter?
Prof Bruno Scheller
Panel discussion
 
13:50
Conclusion & Take home message
 

 

Educational objectives

  • Discuss current trends and approaches of complex cases
  • Learn about indications and clinical evidences
  • Demonstrate advanced techniques and technologies in the treatment of complex cases
  • Provide platform for discussion and mutual learning

Audience

  • This live case is dedicated to interventional cardiologists interested and/or specialized in coronary angioplasty
  • A prerequisite for attendees in an initial knowledge and practice of angioplasty

This session is produced and broadcasted with sonar system by incathlab

Shooting date : 2019-01-21
Last update : 2020-03-04

NSE Alpha / B. Braun

Scoring Balloon Catheter for challenging lesions

SeQuent® Please NEO / B. Braun

Next generation coronary Drug Coated Balloon to treat vascular stenosis
2 comments
Join the Discussion
  • anwar D. Results with Sirolimus coated Drug balloons ??

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    • Daniel W. Excellent question! The DCB technology with Sirolimus is emerging and many companies are active in this field, as BBRAUN, Mynvasis, Concept Medical, Orchestra Biomed. The data are scarce and conclusions preliminary. Seems to have the potential to be equal. Preliminarny clinical data are positive mainly for ISR, less for small vessels. SBut I think can be the choice of the future. As it is difficult to create a DCB with the hydrophilic Sirolimus, there can be differences between the sirolimus DCBs, as senn with the Pclitaxel DCBs. Hope that helps.

        Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
        Your browser doesn't have Flash, Silverlight or HTML5 support.


      Suggestions

      Discover it now!

      Nothing is simple

      Alex & The Young Generation - Ep.9

      Share
      Friday, March 28th 2025 from 08am to 10pm (GMT+1)
      Honolulu : Thursday, March 27th 2025 from 10pm to 12pm (GMT+1)
      San Francisco : Friday, March 28th 2025 from 12am to 02pm (GMT+1)
      New York : Friday, March 28th 2025 from 03am to 05pm (GMT+1)
      Buenos Aires : Friday, March 28th 2025 from 05am to 07pm (GMT+1)
      London / Dublin : Friday, March 28th 2025 from 08am to 10pm (GMT+1)
      Paris / Berlin : Friday, March 28th 2025 from 09am to 11pm (GMT+1)
      Istanbul : Friday, March 28th 2025 from 10am to 12am (GMT+1)
      Moscou / Dubaï : Friday, March 28th 2025 from 12pm to 02am (GMT+1)
      Bangkok : Friday, March 28th 2025 from 03pm to 05am (GMT+1)
      Shanghai : Friday, March 28th 2025 from 04pm to 06am (GMT+1)
      Tokyo : Friday, March 28th 2025 from 05pm to 07am (GMT+1)
      Sydney : Friday, March 28th 2025 from 06pm to 08am (GMT+1)
      Wellington : Friday, March 28th 2025 from 08pm to 10am (GMT+1)

      Complex & High-Risk Indicated Procedures

      Discover the 6th edition - Day #1

      Share
      Wednesday, May 22nd 2024 from 03pm to 04pm (GMT+2)
      Honolulu : Wednesday, May 22nd 2024 from 05am to 06am (GMT+2)
      San Francisco : Wednesday, May 22nd 2024 from 08am to 09am (GMT+2)
      New York : Wednesday, May 22nd 2024 from 11am to 12pm (GMT+2)
      Buenos Aires : Wednesday, May 22nd 2024 from 12pm to 01pm (GMT+2)
      Reykjavik : Wednesday, May 22nd 2024 from 03pm to 04pm (GMT+2)
      London / Dublin : Wednesday, May 22nd 2024 from 04pm to 05pm (GMT+2)
      Paris / Berlin : Wednesday, May 22nd 2024 from 05pm to 06pm (GMT+2)
      Istanbul : Wednesday, May 22nd 2024 from 06pm to 07pm (GMT+2)
      Moscou / Dubaï : Wednesday, May 22nd 2024 from 07pm to 08pm (GMT+2)
      Bangkok : Wednesday, May 22nd 2024 from 10pm to 11pm (GMT+2)
      Shanghai : Wednesday, May 22nd 2024 from 11pm to 12am (GMT+2)
      Tokyo : Thursday, May 23rd 2024 from 12am to 01am (GMT+2)
      Sydney : Thursday, May 23rd 2024 from 02am to 03am (GMT+2)
      Wellington : Thursday, May 23rd 2024 from 04am to 05am (GMT+2)

      DanGER shock trial results and the significance to reduce adverse events

      Share
      Scroll Up
      // //